
Panelists look deeper into the possible challenges or barriers to making an accurate diagnosis of plaque psoriasis

Mark Lebwohl, MD, is dean for clinical therapeutics, and chairman emeritus at the Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

Panelists look deeper into the possible challenges or barriers to making an accurate diagnosis of plaque psoriasis

Shared insight on identifying clinical manifestations of plaque psoriasis and making a timely diagnosis.

A panel of experts review the nature of plaque psoriasis and the mechanism of action of several classes of targeted therapy.

Current therapies for psoriasis can be very effective and are acceptable to many patients. However, a number of drawbacks associated with these treatments may compromise their effectiveness. Patients undergoing ultraviolet B (UVB) phototherapy or psoralen plus ultraviolet A (PUVA) treatments must keep their appointments 3 times a week to maintain the effectiveness of the therapy.